CA3070481A1 - Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids - Google Patents

Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids Download PDF

Info

Publication number
CA3070481A1
CA3070481A1 CA3070481A CA3070481A CA3070481A1 CA 3070481 A1 CA3070481 A1 CA 3070481A1 CA 3070481 A CA3070481 A CA 3070481A CA 3070481 A CA3070481 A CA 3070481A CA 3070481 A1 CA3070481 A1 CA 3070481A1
Authority
CA
Canada
Prior art keywords
emulsion
emulsion composition
fatty acids
fish oil
omega
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3070481A
Other languages
English (en)
French (fr)
Inventor
Mark Puder
Kathleen GURA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of CA3070481A1 publication Critical patent/CA3070481A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3070481A 2017-08-10 2018-08-10 Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids Pending CA3070481A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762543437P 2017-08-10 2017-08-10
US62/543,437 2017-08-10
PCT/US2018/046206 WO2019032959A1 (en) 2017-08-10 2018-08-10 METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND / OR OMEGA-3 FATTY ACIDS

Publications (1)

Publication Number Publication Date
CA3070481A1 true CA3070481A1 (en) 2019-02-14

Family

ID=65271269

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3070481A Pending CA3070481A1 (en) 2017-08-10 2018-08-10 Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids

Country Status (16)

Country Link
US (2) US11324697B2 (enExample)
EP (2) EP3664628B1 (enExample)
JP (1) JP7370317B2 (enExample)
KR (2) KR102677006B1 (enExample)
CN (3) CN118000419A (enExample)
AU (1) AU2018313260B2 (enExample)
CA (1) CA3070481A1 (enExample)
DK (1) DK3664628T3 (enExample)
ES (1) ES3012510T3 (enExample)
FI (1) FI3664628T3 (enExample)
HR (1) HRP20250125T1 (enExample)
PH (1) PH12020500267A1 (enExample)
PL (1) PL3664628T3 (enExample)
PT (1) PT3664628T (enExample)
SG (2) SG11202000592WA (enExample)
WO (1) WO2019032959A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230113738A1 (en) * 2020-03-06 2023-04-13 Optimega Llc Fatty acid compositions for enteral use
WO2021243526A1 (zh) * 2020-06-01 2021-12-09 苏州大学附属儿童医院 新生儿肠外营养相关性肝病特异性标志物lncRNA的应用
US20230241124A1 (en) * 2020-07-14 2023-08-03 Nutrition Lipid Developments Isotonic lipid emulsion
KR20230010404A (ko) 2021-07-12 2023-01-19 에이치케이이노엔 주식회사 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제
CN116754711B (zh) * 2023-08-17 2023-11-07 蓝星安迪苏南京有限公司 饲料用乳化剂的乳化能力评估方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2738253A1 (de) 1977-08-25 1979-03-01 Dabisch Tipp Ex Tech Koerper mit reversibel temperaturabhaengiger transparenz
DE2749265A1 (de) 1977-11-03 1979-05-10 Linde Ag Verfahren zur biologischen reinigung von abwasser
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
JPS61501558A (ja) * 1984-01-16 1986-07-31 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド 中および長鎖トリグリセライドの非経口栄養補給
US4752618A (en) 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
DE3722540A1 (de) 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
DE3903056A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
SE9101642D0 (sv) 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
WO1993009772A1 (fr) 1991-11-14 1993-05-27 Sagami Chemical Research Center Medicament contre des maladies hepatiques
US5728385A (en) 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
JP2000501131A (ja) * 1995-11-24 2000-02-02 ロダース・クロックラーン・ビー・ブイ 魚油をベースとする組成物
ATE230262T1 (de) * 1995-11-28 2003-01-15 Braun Melsungen Ag Lipidemulsionen mit optimierter hydrolyse sowie deren verwendung
US20030068385A1 (en) 2001-03-23 2003-04-10 Moyer Mary Pat Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy
CA2452401C (en) * 2001-07-02 2013-02-26 Suntory Limited Process for producing fat comprising triglyceride containing highly unsaturated fatty acid
EP1279400A1 (en) * 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
FI114894B (fi) 2002-05-02 2005-01-31 Omecol Finland Oy Elintarvikekoostumus
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
CA2545752C (en) * 2003-11-12 2013-03-26 Children's Medical Center Corporation Treatment and prevention of liver disease associated with parenteral nutrition (pn)
EP1723096A4 (en) * 2004-03-04 2008-03-05 Htl High Tech Lipids Ltd TRIGLYCERIDES STRUCTURES AND EMULSIONS CONTAINING THESE TRIGLYCERIDES
CA2573054C (en) * 2004-07-02 2012-10-09 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
CN1965806A (zh) * 2006-11-09 2007-05-23 华瑞制药有限公司 一种含大豆油、中链甘油三酯、橄榄油和鱼油的脂肪乳注射液及其制造方法
US7666828B2 (en) * 2008-01-22 2010-02-23 Stepan Company Sulfonated estolides and other derivatives of fatty acids, methods of making them, and compositions and processes employing them
US8241672B2 (en) 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20120277316A1 (en) 2010-01-19 2012-11-01 University of Tennesse Research Foundation a university Methods and compositions for treating and preventing parenteral nutrition associated liver disease
WO2011133841A2 (en) * 2010-04-23 2011-10-27 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Intravenous omega-3 fatty acid compositions & method of use
US10052352B2 (en) * 2011-06-15 2018-08-21 Stable Solutions Llc Therapeutic application of parenteral krill oil
JP5864735B2 (ja) 2011-06-15 2016-02-17 ステイブル ソリューションズ エルエルシーＳｔａｂｌｅ Ｓｏｌｕｔｉｏｎｓ Ｌｌｃ 非経口オキアミ油の治療用途
WO2013063067A1 (en) 2011-10-24 2013-05-02 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
WO2013127727A1 (en) * 2012-02-29 2013-09-06 B. Braun Melsungen Ag Hormone containing emulsion comprising krill phospholipids
WO2016040570A2 (en) * 2014-09-12 2016-03-17 Children's Medical Center Corporation Dietary emulsion formulations and methods for using the same
JP6814148B2 (ja) 2015-03-31 2021-01-13 フレゼニウス カービ ドイチュラント ゲーエムベーハー 非経口投与用のエマルション

Also Published As

Publication number Publication date
JP7370317B2 (ja) 2023-10-27
ES3012510T3 (en) 2025-04-09
CN118000419A (zh) 2024-05-10
RU2020109759A3 (enExample) 2021-11-15
CN111093399A (zh) 2020-05-01
AU2018313260B2 (en) 2024-06-20
HRP20250125T1 (hr) 2025-03-28
KR20200038472A (ko) 2020-04-13
EP4450090A3 (en) 2025-01-29
PT3664628T (pt) 2024-12-31
US20200345638A1 (en) 2020-11-05
PH12020500267A1 (en) 2020-09-21
PL3664628T3 (pl) 2025-04-07
DK3664628T3 (da) 2025-01-13
RU2020109759A (ru) 2021-09-10
US11324697B2 (en) 2022-05-10
SG10202108769WA (en) 2021-09-29
WO2019032959A1 (en) 2019-02-14
EP3664628A4 (en) 2021-04-14
EP4450090A2 (en) 2024-10-23
AU2018313260A1 (en) 2020-01-16
JP2020530464A (ja) 2020-10-22
US20220226238A1 (en) 2022-07-21
KR20240101693A (ko) 2024-07-02
KR102677006B1 (ko) 2024-06-25
SG11202000592WA (en) 2020-02-27
EP3664628B1 (en) 2024-12-11
FI3664628T3 (fi) 2025-02-04
BR112020002638A2 (pt) 2020-08-18
EP3664628A1 (en) 2020-06-17
CN117918525A (zh) 2024-04-26

Similar Documents

Publication Publication Date Title
US20220226238A1 (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
AU2010201897B2 (en) Dietary supplement composition for blood lipid health
Mannarino et al. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study
JP2015523360A (ja) 小児メタボリック症候群を治療する方法
KR20210016570A (ko) Gpc를 포함하는 비경구 영양을 위한 지질 에멀젼
Taha et al. Lipid-lowering activity of natural and semi-synthetic sterols and stanols
Fell et al. Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution
CN106470675A (zh) 严重高甘油三酯血症的治疗
CN103813790A (zh) Gip上升抑制剂
RU2783166C9 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
RU2783166C2 (ru) Способы и композиции, относящиеся к эмульсиям, содержащим рыбий жир и/или омега-3 жирные кислоты
HK40023767A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
HK40023767B (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
JP2010229099A (ja) 脂質異常症の改善または治療薬
BR112020002638B1 (pt) Métodos e composições relativas a emulsões compreendendo óleo de peixe e/ou ácidos graxos ômega-3
HK40022806A (en) Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
AU2022406916A1 (en) Methods and compositions relating to treatment and prevention of fatty acid deficiencies
WO2020259493A1 (en) Compositions and methods for the prevention or treatment, or dietary management of nafld
WO2013005834A1 (ja) 高純度ｅｐａを含有する抗肥満剤
US20250009657A1 (en) Lipid emulsions for parenteral nutrition
US20250009699A1 (en) Lipid emulsions for parenteral nutrition
JP7422160B2 (ja) アクアポリン３の発現調節を介した腸機能改善用組成物及びその使用
US20250108028A1 (en) Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230807